Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
56,455.33 -1,747.40 (-3.00%) CMC Crypto 200
1,173.35 -35.34 (-2.93%)
Oxford Biomedica plc (OXB.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:35PM BST
| Previous close | 332.50 |
| Open | 328.08 |
| Bid | 285.00 x 0 |
| Ask | 345.00 x 0 |
| Day's range | 326.50 - 334.37 |
| 52-week range | 164.29 - 460.00 |
| Volume | |
| Avg. volume | 244,843 |
| Market cap | 347.506M |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Oxford Biomedica plc (LON:OXB) is favoured by institutional owners who hold 53% of the company
Key Insights Significantly high institutional ownership implies Oxford Biomedica's stock price is sensitive to their...
- Simply Wall St.
Oxford Biomedica (LON:OXB) investors are sitting on a loss of 71% if they invested three years ago
Oxford Biomedica plc ( LON:OXB ) shareholders will doubtless be very grateful to see the share price up 89% in the last...
- Simply Wall St.
Oxford Biomedica Full Year 2023 Earnings: Misses Expectations
Oxford Biomedica ( LON:OXB ) Full Year 2023 Results Key Financial Results Revenue: UK£89.5m (down 36% from FY 2022...
© 2024 Yahoo. All rights reserved.